FDA Inspection 1215694 — Chang Kuo Chou Pharmaceutical Co., Ltd.

Chang Kuo Chou Pharmaceutical Co., Ltd. — FEI 3007086810

The FDA completed an inspection of Chang Kuo Chou Pharmaceutical Co., Ltd. on July 21, 2023 in Taoyuan City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 21, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Taoyuan City (Taiwan)